Shenzhen Hybio Pharmaceutical (revision 1)
Old revision·18:47, 14 Aug 2025·TelehealthTruus
This is an old revision of this page, as it stood at 18:47, 14 Aug 2025, saved by TelehealthTruus with the summary start organisation article — registry facts and product scope only. It may differ substantially from the current revision, and any error it contains may since have been corrected.
| Shenzhen Hybio Pharmaceutical Co., Ltd. | |
|---|---|
| Legal name | Shenzhen Hybio Pharmaceutical Co., Ltd. |
| Trading name | HYB |
| Other designations | Hybio, Hybio Pharmaceutical, 深圳翰宇药业股份有限公司 |
| Organisation infobox · conventions | |
Shenzhen Hybio Pharmaceutical Co., Ltd. (trading as HYB; hybiopharmaceutical.com) is a peptide active-ingredient manufacturer and contract development organisation trading as HYB from Shenzhen, Guangdong, China, incorporated in 2003 and supplying research peptides and raw materials with batch documentation.[1][2]
The organisation is one of twenty-two covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]
References
- ^ National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
- ^ Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
- ^ Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
Categories: